Arena’s Diet Pill May Spur Renewed Race From Drugmakers

Arena Pharmaceuticals Inc.’s weight-loss pill, the first cleared in the U.S. in 13 years, and an expected rival are potential breakthroughs in the treatment of obesity that may spur major drugmakers into the market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.